A new proposition for the screening of platelet function defects using an hematology analyzer

Area of Science:

• Hematology
• Clinical Diagnostics
• Platelet Physiology

Background:

• Congenital thrombopathies are inherited bleeding disorders affecting platelet function.
• Current screening methods for thrombopathies can be limited in scope and sensitivity.
• Hematology analyzers offer advanced capabilities for detailed blood cell analysis.

Purpose of the Study:

• To propose an improved method for congenital thrombopathy screening using hematology analyzers.
• To leverage novel optical platelet parameters for enhanced detection of platelet activation.
• To refine the platelet count ratio principle for more accurate screening.

Main Methods:

• Utilizing an optical hematology analyzer (e.g., ADVIA 2120i) for platelet analysis.
• Applying a platelet agonist to whole blood samples to induce platelet activation.
• Monitoring changes in platelet count and novel morphological/structural parameters post-activation.
• Improving the existing platelet count ratio principle.

Main Results:

• The proposed method detects morphological and structural platelet changes indicative of activation.
• These changes are expected to reflect platelet responsiveness in congenital thrombopathies.
• The novel parameters offer a more detailed assessment compared to traditional methods.

Conclusions:

• The new hematology analyzer-based method shows promise for improved congenital thrombopathy screening.
• Detection of platelet morphological and structural changes provides valuable diagnostic information.
• This approach enhances the sensitivity and scope of platelet function testing.